Personal Background
Personal Background Prof. Dr. med. Marcus Maurer Executive Director of the Institute of Allergology at the Charité – Universitätsmedizin Berlin Co-Director of Immunology and Allergology at the
Found 522 hits.
Personal Background Prof. Dr. med. Marcus Maurer Executive Director of the Institute of Allergology at the Charité – Universitätsmedizin Berlin Co-Director of Immunology and Allergology at the
111. | Maurer, M., Church, M. K., Marsland, A. M., Sussman, G., Siebenhaar, F., Vestergaard, C., and Broom, B.: Questions and answers in chronic urticaria: where do we stand and where do we go? J. Eur. Acad. Dermatol. Venereol. 2016: 30, Suppl. 5; 7-15. IF: 3.52 |
r.111
240 | Siebenhaar, F.+, von Tschirnhaus, E., Hartmann, K., Rabenhorst, A., Staubach, P., Peveling-Oberhag, A., Wagner, N., Martus, P., Carter, M. C., Metcalfe, D. D., Church, M. K., Maurer, M. and Weller, K.: Development and Validation of the Mastocytosis Quality of Life questionnaire: MC-QoL. Allergy 2016: 71; 869-877. IF: 7.36 |
132 | Weller, K., Viehmann, K., Bräutigam, M., Krause, K., Siebenhaar, F., Zuberbier, T., and Maurer, M.+: Cost-intensive, time-consuming, problematical? – How physicians in private practice experience the care of urticaria patients. J. Dtsch. Dermatol. Ges. 2012: 10; 341-347. IF: 1.40 |
145 | Weller, K., Viehmann, K., Bräutigam, M., Krause, K., Siebenhaar, F., Zuberbier, T., and Maurer, M.+: Management of chronic spontaneous urticaria in real life – in accordance with the guidelines? A cross-sectional physician-based survey study. J. Eur. Acad. Dermatol. Venereol. 2013: 27; 43-50. IF: 2.78 |
400. | Maurer, M.+, Costa, C., Giménez-Arnau, A., Guillet, G., Labrador-Horrillo, M., Lapeere, H., Meshkova, R., Savic, S., and Chapman-Rothe, N.: Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study. Clin. Exp. Allergy 2020: 50; 1166-1175 IF: 5.02 |
o.400
45 | Weller, K., Foitzik, F., Paus, R., Syska, W., and Maurer, M.+: Mast cells are required for normal healing of skin wounds in mice. FASEB J. 2006: 20; 2366-2368. IF: 6.72 |
296 | Ruft, J., Asady, A., Staubach, P., Casale, T., Sussman, G., Zuberbier, T., Maurer, M. Weller, K., and Altrichter, S.+: Development and validation of the cholinergic urticaria quality of life questionnaire: CholU-QoL. Clin. Exp. Allergy 2018: 48; 433-444. IF: 4.74 |
274 | Maurer, M.*, Staubach, P.*, Raap, U.*, Richter-Huhn, G.*, Bauer, A., Ruëff, F., Jakob, T., Yazdi, A. S., Mahler, V., Wagner, N., Lippert, U., Hillen, U., Schwinn, A., Pawlak, M., Behnke, N., Chaouche, K., and Chapman-Rothe, N.: H1-antihistamine-refractory chronic spontaneous urticaria: It’s worse than we thought – first results of the multicenter real-life AWARE study. Clin. Exp. Allergy 2017: 47; 684-692. IF: 5.16 |
280 | Asady, A., Ruft, J., Ellrich, A., Hawro, T., Maurer, M.+, and Altrichter, S.: Cholinergic urticaria patients of different age groups have distinct features. Clin. Exp. Allergy 2017: 47; 1609-1614. IF: 5.16 |